Хлебные крошки
- Главная
-
Аналитика
-
Акции
Акции внутренные
Apyx Medical Corporation APYX
$5.60
+$1.4 (25.00%)
На 18:01, 12 мая 2023
+51.79%
Потенциал через год
Ранг: 3
Ключевые показатели
-
Marketcap
143580870.00000000
-
week52high
11.16
-
week52low
1.31
-
Revenue
44510000
-
P/E TTM
-5
-
Beta
1.31072600
-
EPS
-0.73000000
-
Last Dividend
0.00000000
-
Next Earnings Date
11 мая 2023 г. в 12:00
Описание компании
Apyx Medical Corporation, an energy technology company, develops, manufactures, and sells medical devices in the cosmetic and surgical markets worldwide. The company operates in two segments, Advanced Energy and Original Equipment Manufacturing (OEM). It offers Helium Plasma Generator for delivery of RF energy and helium to cut, coagulate and ablate soft tissue during open and laparoscopic surgical procedures. The company offers Renuvion branded products for the cosmetic surgery market that enable plastic surgeons, fascial plastic surgeons, and cosmetic physicians to provide controlled heat to the tissue to achieve their desired results; and J-Plasma branded products for the hospital surgical market. It also develops, manufactures, and sells disposable hand pieces, and OEM generators and accessories. The company was formerly known as Bovie Medical Corporation and changed its name to Apyx Medical Corporation in January 2019. Apyx Medical Corporation was incorporated in 1982 and is based in Clearwater, Florida.
Рекомендации
аналитиков
Рекомендации аналитиков
| Grading company | New grade | Previous grade | Recommendation date |
|---|---|---|---|
| Piper Sandler | Overweight | Overweight | 12 авг 2022 г. |
| Lake Street | Buy | Buy | 19 июл 2022 г. |
| Lake Street | Buy | 20 мая 2022 г. | |
| JMP Securities | Market Outperform | Market Outperform | 13 авг 2021 г. |
| JMP Securities | Market Outperform | Market Outperform | 12 мая 2020 г. |
Свежие комментарии
Свежие комментарии
Оставьте свой голос
Оставьте свой голос
Анонимное голосование
Будет ли рост российского рынка к концу года?
-
Да
87% -
Нет
12%
Проголосовал 8 человек
Новостная лента
компании
Insider Summary
Insider Summary
| Reporting Name | Acquistion/Disposition | Owned | Transacted | Transaction Date |
|---|---|---|---|---|
| Goodwin Charles D. II | A | 243000 | 243000 | 11 янв 2023 г. |
| Semb Tara | A | 96000 | 96000 | 11 янв 2023 г. |
| CITRONOWICZ MOSHE | A | 72000 | 72000 | 11 янв 2023 г. |
| Hornsby Todd | A | 100000 | 100000 | 11 янв 2023 г. |
| Goodwin Charles D. II | A | 40000 | 9750 | 29 авг 2022 г. |
| Goodwin Charles D. II | A | 30250 | 2000 | 29 авг 2022 г. |
| Waldman Lawrence | A | 17000 | 17000 | 11 авг 2022 г. |
| MAKRIDES ANDREW | A | 17000 | 17000 | 11 авг 2022 г. |
| Andres John C. | A | 17000 | 17000 | 11 авг 2022 г. |
| Baylor-Henry Minnie | A | 37000 | 37000 | 11 авг 2022 г. |
Новостная лента
Apyx Medical Corporation (APYX) Q1 2023 Earnings Call Transcript
Seeking Alpha
11 мая 2023 г. в 10:21
Apyx Medical Corporation (NASDAQ:APYX ) Q1 2023 Earnings Conference Call May 11, 2023 8:00 AM ET Company Participants Charlie Goodwin - President & CEO Tara Semb - CFO Conference Call Participants Matthew O'Brien - Piper Sandler Matt Hewitt - Craig-Hallum Capital Group Operator Hello and welcome, ladies and gentlemen, to the First Quarter of Fiscal Year 2023 Earnings Conference Call for Apyx Medical Corporation. At this time, all participants have been placed in a listen-only mode.
Apyx Medical Corporation to Release Fourth Quarter and Fiscal Year 2022 Financial Results on March 16, 2023
Business Wire
16 февр 2023 г. в 07:30
CLEARWATER, Fla.--(BUSINESS WIRE)--Apyx Medical Corporation (NASDAQ:APYX) (the “Company”), the manufacturer of a proprietary helium plasma and radiofrequency technology marketed and sold as Renuvion®, today announced that financial results for the fourth quarter and fiscal year 2022 will be released before the market opens on Thursday, March 16th. Management will host a conference call at 8:00 a.m.
Archon Capital Ups Stake in Apyx Medical (APYX) After Q3 Results
24/7 Wall Street
23 ноя 2022 г. в 04:22
Fintel reports that Archon Capital Management LLC has filed a 13G/A form with the SEC disclosing ownership of 3,452,030 shares of Apyx Medical Corp (APYX).
Apyx Medical Corporation (APYX) Q3 2022 Earnings Call Transcript
Seeking Alpha
13 ноя 2022 г. в 23:28
Apyx Medical Corporation (NASDAQ:APYX ) Q3 2022 Earnings Conference Call November 10, 2022 8:00 AM ET Company Participants Charles Goodwin - President and Chief Executive Officer Tara Semb - Chief Financial Officer Conference Call Participants Matt Hewitt - Craig-Hallum Capital Group Matthew O'Brien - Piper Sandler Kyle Bauser - Lake Street Capital Markets Dave Turkaly - JMP Securities Russell Cleveland - RENN Capital Operator Hello and welcome, ladies and gentlemen to Third Quarter of 2022 Earnings Conference Call for Apyx Medical Corporation. At this time, all participants have been placed in listen-only mode.
Apyx Medical (APYX) Reports Q3 Loss, Misses Revenue Estimates
Zacks Investment Research
10 ноя 2022 г. в 09:47
Apyx (APYX) delivered earnings and revenue surprises of -41.67% and 24.05%, respectively, for the quarter ended September 2022. Do the numbers hold clues to what lies ahead for the stock?